{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:09:59Z","timestamp":1789412999808,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jval.2021.06.004","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T23:08:48Z","timestamp":1627513728000},"page":"1737-1745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Lifetime Health and Economic Outcomes of Active Surveillance, Radical Prostatectomy, and Radiotherapy for Favorable-Risk Localized Prostate Cancer"],"prefix":"10.1016","volume":"24","author":[{"given":"Koen","family":"Degeling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall M.","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Pereira-Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anis A.","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar","family":"Siva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten J.","family":"IJzerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jval.2021.06.004_bib1","first-page":"683","article-title":"Clinically localized prostate cancer: AUA\/ASTRO\/SUO guideline. Part I: risk stratification, shared decision making, and care options","volume":"199","author":"Sanda","year":"2018","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.jval.2021.06.004_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on prostate Cancer-2020 Update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.jval.2021.06.004_bib3","article-title":"A\u00a0systematic review and meta-analysis of prostate cancer utility values of patients and partners between 2007 and 2016","volume":"4","author":"Magnus","year":"2019","journal-title":"MDM Policy Pract"},{"issue":"37","key":"10.1016\/j.jval.2021.06.004_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta24370","article-title":"Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT","volume":"24","author":"Hamdy","year":"2020","journal-title":"Health Technol Assess"},{"issue":"7","key":"10.1016\/j.jval.2021.06.004_bib5","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41416-020-0978-4","article-title":"The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer","volume":"123","author":"Noble","year":"2020","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.jval.2021.06.004_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1186\/s12885-020-07276-4","article-title":"Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial","volume":"20","author":"Sanghera","year":"2020","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.jval.2021.06.004_bib7","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jval.2012.04.013","article-title":"Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4","volume":"15","author":"Karnon","year":"2012","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.jval.2021.06.004_bib8","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1524-4733.2010.00775.x","article-title":"Discrete event simulation: the preferred technique for health economic evaluations?","volume":"13","author":"Caro","year":"2010","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2021.06.004_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canep.2018.09.008","article-title":"Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients","volume":"57","author":"Degeling","year":"2018","journal-title":"Cancer Epidemiol"},{"issue":"8","key":"10.1016\/j.jval.2021.06.004_bib10","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/jso.23584","article-title":"Active surveillance for clinically localized prostate cancer--a systematic review","volume":"109","author":"Thomsen","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.jval.2021.06.004_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"15","key":"10.1016\/j.jval.2021.06.004_bib13","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects","volume":"21","author":"Royston","year":"2002","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.jval.2021.06.004_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.diii.2020.05.007","article-title":"Candidates to salvage therapy after external-beam radiotherapy of prostate cancer: predictors of local recurrence volume and metastasis-free survival","volume":"102","author":"Maoui","year":"2021","journal-title":"Diagn Interv Imaging"},{"issue":"1","key":"10.1016\/j.jval.2021.06.004_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0272989X18814770","article-title":"Comparing strategies for modeling competing risks in discrete-event simulations: a simulation study and illustration in colorectal cancer","volume":"39","author":"Degeling","year":"2019","journal-title":"Med Decis Making"},{"issue":"6","key":"10.1016\/j.jval.2021.06.004_bib17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.eururo.2018.02.001","article-title":"Burden of metastatic castrate naive prostate cancer patients, to identify men more likely to benefit from early docetaxel: further analyses of CHAARTED and GETUG-AFU15 studies","volume":"73","author":"Gravis","year":"2018","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.jval.2021.06.004_bib18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/bju.13582","article-title":"Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life","volume":"118","author":"Lane","year":"2016","journal-title":"BJU Int"},{"issue":"6B","key":"10.1016\/j.jval.2021.06.004_bib19","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1111\/bju.13122","article-title":"Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up","volume":"117","author":"Watson","year":"2016","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.jval.2021.06.004_bib20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11136-014-0794-5","article-title":"Mapping FACT-P to EQ-5D in a large cross-sectional study of metastatic castration-resistant prostate cancer patients","volume":"24","author":"Diels","year":"2015","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.jval.2021.06.004_bib22","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/bju.13317","article-title":"Patterns-of-care and health economic analysis of robot-assisted radical prostatectomy in the Australian public health system","volume":"117","author":"Basto","year":"2016","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.jval.2021.06.004_bib23","doi-asserted-by":"crossref","first-page":"91.e7","DOI":"10.1016\/j.urolonc.2017.10.024","article-title":"Estimating the healthcare costs of treating prostate cancer in Australia: a Markov modelling analysis","volume":"36","author":"Gordon","year":"2018","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.jval.2021.06.004_bib25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12874-017-0437-y","article-title":"Accounting for parameter uncertainty in the definition of parametric distributions used to describe individual patient variation in health economic models","volume":"17","author":"Degeling","year":"2017","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"10.1016\/j.jval.2021.06.004_bib26","first-page":"964","article-title":"Cost-effectiveness of active surveillance, radical prostatectomy and external beam radiotherapy for localized prostate cancer: an analysis of the ProtecT trial","volume":"202","author":"Sharma","year":"2019","journal-title":"J\u00a0Urol"},{"issue":"34","key":"10.1016\/j.jval.2021.06.004_bib27","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1200\/JCO.18.01097","article-title":"Hypofractionated radiation therapy for localized prostate cancer: an ASTRO, ASCO, and AUA evidence-based guideline","volume":"36","author":"Morgan","year":"2018","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301521015928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301521015928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:24:48Z","timestamp":1761096288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301521015928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1098301521015928"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2021.06.004","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lifetime Health and Economic Outcomes of Active Surveillance, Radical Prostatectomy, and Radiotherapy for Favorable-Risk Localized Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2021.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}